Cite
Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection.
MLA
Wolszczak-Biedrzycka, Blanka, et al. “Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection.” Vaccines, vol. 10, no. 5, May 2022, p. 741. EBSCOhost, https://doi.org/10.3390/vaccines10050741.
APA
Wolszczak-Biedrzycka, B., Bieńkowska, A., Zaborowska, J. E., Smolińska-Fijołek, E., Biedrzycki, G., & Dorf, J. (2022). Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection. Vaccines, 10(5), 741. https://doi.org/10.3390/vaccines10050741
Chicago
Wolszczak-Biedrzycka, Blanka, Anna Bieńkowska, Joanna Ewa Zaborowska, Elwira Smolińska-Fijołek, Grzegorz Biedrzycki, and Justyna Dorf. 2022. “Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection.” Vaccines 10 (5): 741. doi:10.3390/vaccines10050741.